Invesco NASDAQ 100 ETF (QQQM)

As of October 2025, the United States market is witnessing a remarkable surge, with Technology, Energy, and Cryptocurrency Exchange-Traded Funds (ETFs) spearheading significant gains. This outperformance is not merely a cyclical upturn but a profound reflection of an economy increasingly shaped by relentless innovation, shifting global energy dynamics, and the pervasive, transformative influence of Artificial [...]

This popular ETF based on the Nasdaq-100 is still beating the S&P 500.

Macroeconomist Henrik Zeberg said on Saturday that Bitcoin (CRYPTO: BTC) and the Nasdaq stock index are in a tech-driven bubble, predicting a crash that could bring both assets back to 2022 levels.

Tech-saturated Nasdaq 100 ETFs hit record highs despite U.S. tariff hike. Leading the pack were Invesco's QQQ, QQQM and QQQE. Strong performance driven by confident investors and stable big-cap techs.

Hedge funds poured billions into tech stocks such as Nvidia, Microsoft, Amazon, Tesla during Q1. Even ETFs like the IVV, experienced big inflows.

CSPC will receive an upfront payment of $110 million as part of the agreement, and is eligible to receive up to $1.62 billion in potential development milestone payments and up to $3.6 billion in sales milestone payments.

The firm raised its price target on Netflix to $1,350 from $1,150 and kept an ‘Outperform’ rating.

Both trials were conducted during the COVID-19 pandemic, a factor the companies said may have influenced the outcomes.

The company’s revenue rose 7%, with games and related services sales gaining 12%.

Baidu plans to test its Apollo Go robotaxi service in Switzerland, expanding internationally amid fierce competition, even as strict European regulations pose delays.

The approval is based on positive results from a phase 3 trial, which demonstrated that Calquence plus bendamustine and rituximab reduced the risk of disease progression or death by 27% compared to standard-of-care chemoimmunotherapy.

AstraZeneca said on Friday that the full results from the two trials will be shared with regulatory authorities and presented at an upcoming medical meeting.

Lucid senior vice president Derek Jenkins told Reuters that a “lot of crazy things going on in the world” can affect the timeline, but the company is currently on track to launch a competitor to Tesla’s Model Y SUV next year.

Investing might look easy for some, but that isn’t always the case.

Lucid will take over Nikola's former Coolidge manufacturing facility and the Phoenix facility, which was previously Nikola's headquarters and product development center.

Building a strong investment portfolio requires an allocation for growth, one for stability, and a last one for income, especially when it comes to planning for retirement.